SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study is a randomized, open-label, controlled, phase III study to evaluate the efficacy and safety of SHR-A1921 versus investigator\'s choice of chemotherapy in patients with platinum-resistant recurrent epithelial ovarian cancer.
Epistemonikos ID: 4a18d8ac9472b542b771c962c013c184b9917651
First added on: May 16, 2024